Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data?

Minerva Urol Nephrol. 2024 Feb;76(1):120-123. doi: 10.23736/S2724-6051.23.05640-9.

Giulio Francolini^{1

2}, Laura Marandino^{2

3}, Chiara Ciccarese^{2

4}, Alessio Pecoraro^{2

5}, Daniele Amparore^{6

7}, Riccardo Campi^{2

5}; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group

European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group:
Riccardo Bertolo, Leonardo D Borregales, Anna Caliò, Umberto Carbonara, Pietro Diana, Selcuk Erdem, Michele Marchioni, Stijn Muselaers, Carlotta Palumbo, Nicola Pavan, Angela Pecoraro, Eduard Roussel, Hannah Warren, Zhenjie Wu

¹ Unit of Radiation Oncology, Careggi University Hospital, Florence, Italy.
² European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, the Netherlands.
³ Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK.
⁴ Unit of Medical Oncology, Comprehensive Cancer Center, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
⁵ Unit of Urological Robotic Surgery and Renal Transplantation, Careggi University Hospital, University of Florence, Florence, Italy.
⁶ European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, the Netherlands - danieleamparore@hotmail.it.
⁷ Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy.

No abstract available

MeSH terms